Abstract:The peptide hormone amylin receptor is a complex of the calcitonin receptor (CTR) and an accessory protein called receptor activity-modifying proteins (RAMPs). The soluble extracellular domain (ECD) of CTR is an important binding site of peptide hormone calcitonin. RAMPs also have an ECD and the association of CTR ECD with RAMP ECD enhances the affinity of peptide hormone amylin. However, the mechanism of how RAMP ECD association enhances amylin affinity remains elusive. Here, we report evidence supporting direct molecular interaction between an antagonistic amylin analog AC413 and RAMP2 ECD. We measured FITC-labeled peptide affinity for purified receptor ECD using fluorescence polarization (FP). We first found that RAMP2 ECD addition to maltose-binding protein (MBP)-tagged CTR ECD and an engineered MBP-tagged RAMP2 ECD-CTR ECD fusion protein (MBP-RAMP2-CTR ECD fusion) enhanced AC413 affinity. This suggests that these recombinant ECD systems represent functional amylin receptors. Interestingly, AC413 C-terminal residue Tyr25 (Y25) to Pro mutation eliminated its selective affinity for the MBP-RAMP2-CTR ECD fusion suggesting the critical role of the AC413 C-terminal residue in amylin receptor selectivity. Our structural model of the RAMP2 ECD:CTR ECD complex predicted molecular interaction of AC413 C-terminal residue Y25 with RAMP2 Glu101 (E101). Our FP peptide-binding assay showed that the RAMP2 E101A mutation of MBP-RAMP2-CTR ECD fusion decreased AC413 affinity by 7-fold, while the affinity of AC413 with the Y25P mutation was minimally changed. Consistently, AC413 binding affinity for the MBP-free RAMP2-CTR ECD fusion protein was also markedly decreased by the RAMP2 E101A mutation, while the affinity of AC413 with the Y25P mutation was moderately decreased. Together, our results support the molecular interaction between the AC413 C-terminal residue Y25 and RAMP2 E101 expanding our understanding of how the accessory protein RAMP2 enhances affinity of peptide hormone amylin for its receptor.

Platelet aggregation inhibitory activity of mutant proinsulin with C-peptide replaced by CRGDSC sequence

Inhibition of Platelet Aggregation of A Mutant Proinsulin Molecule Engineered by Introduction of A Native Arg-Gly-Asp Sequence

Gene Construction, Expression, Purification and Activity Analysis of Anti-platelet Aggregation Peptide RGD226

Effect of disulfide bond on the conformation and anticoagulant activity of an Arg-Gly-Asp motif displayed on a mutant insulin protein framework

Intra-A Chain Disulfide Bond (A6-11) of Insulin is Essential for Displaying Its Activity

(A6,A11)-MUTANT PROINSULIN AS A SCAFFOLD FOR PRESENTING EXOGENOUS FUNCTIONAL-MOTIFS

Effects of Deletion and Shift of the A20-B19 Disulfide Bond on the Structure, Activity, and Refolding of Proinsulin.

CONSTRUCTION AND EXPRESSION OF INTRA-A CHAIN DISULFIDE BOND SHIFT MUTANT IN HUMAN PROINSULIN GENE

Acidic Residues on the N-Terminus of Proinsulin C-Peptide Are Important for the Folding of Insulin Precursor

Preparation of Tyr-C-peptide from genetically altered human insulin precursor.

Construction of Met-Lys-double-C peptide human proinsulin gene and its expression and characterization

Cloning of CTB-PROIN fusion gene and its expression in Escherichia coli]

Clues to the Design of Aggregation-Resistant Insulin from Proline Scanning of Highly Amyloidogenic Peptides Derived from the N-Terminal Segment of the A-Chain

Characteristic, Activity and Conformational Studies of [A6-Ser, A11-Ser]-insulin.

Efects of Deleting A19 Tyrosine Form Insulin

Expression of Human Globular Adiponectin-Glucagon-like Peptide-1 Analog Fusion Protein and Its Assay of Glucose-Lowering Effect in Vivo.

Influence of A7-B7 disulfide bond deletion on the refolding and structure of proinsulin

Molecular interaction of an antagonistic amylin analog with the extracellular domain of receptor activity-modifying protein 2 assessed by fluorescence polarization

A Study on the Expression of Site-Directed Mutated Human Proinsulin Gene in Non-Β Cell Lines

Flexibility Exists in the Region of [A6-A11, A7-B7] Disulfide Bonds During Insulin Precursor Folding.

Differential processing of pro-glucose-dependent insulinotropic polypeptide in gut